Unlike GLP-1 agonists that reduce appetite or growth hormone peptides that stimulate lipolysis, the compound addresses fat metabolism at the enzymatic level: it removes the molecular governor that locks adipocytes into a low-energy-expenditure state, potentially restoring normal metabolic function in fat tissue where NNMT is overexpressed
This is why we view it as one component of a larger, personalized health strategy designed for lasting performance, not just a temporary fix
Together, they support body recomposition, meaning fat loss with muscle maintenance or even gain
Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen
Licensed Peptides products are developed using industry-standard synthesis and purification protocols, making them suitable for in vitro research, analytical testing, and experimental models